Series A Fundraising
Paris, April 29, 2019 - KEEN EYE raises EUR 6 Million to empower biomedical labs with AI.
This funding will enable the company to deploy internationally its latest machine learning technologies for laboratories and biomedical research.
Jp Morgan / Biotech Showcase
San Francisco, Jan 12-15, 2020 - Sylvain Berlemont, CEO of KEEN EYE, will attend JP Morgan. Feel free to send us an invite on the Partnering platform.
Manchester, Feb 18-20, 2020 - Let’s meet us at Biomarker Series in Manchester to discuss how our solutions can fit with key opportunities and challenges in biomarker research.
International Molecular Medicine Tri-Con
San Francisco, March 1-4, 2020 - We will attend Med TriCon. If you plan to attend, we would be interested in meeting up! To schedule a meeting, please contact us: firstname.lastname@example.org
Immuno-Oncology Summit Europe
London, March 9-12, 2020 - KEEN EYE is attending the Immuno-Oncology Summit Europe in London. We'd be happy to share ideas on IO.
Paris, March 23-25, 2020 - We’ll be very interested to meet you and talk about our AI solutions.
They are talking about Keen Eye
Keen Eye: Fighting Cervical Cancer: A Deep Learning Solution to Help the Screening of the Disease
Keen Eye and Iris Pharma team up to bring Artificial Intelligence in Ophthalmology studies
HalioDx and Keen Eye partner to empower IMMUNOSCORE® with Artificial Intelligence